 |
|
|
ED from prostate cancer hormone therapy treatableMen with advanced prostate cancer may be given androgen deprivation (hormone) therapy to stop their production of testosterone, which may drive tumor growth. Erectile dysfunction is "grossly underreported" by men treated with androgen deprivation (hormone) therapy, Dr. Ithaar H. Derweesh told Reuters Health. Moreover, "studies that have been reported in the literature have tended to focus on decreased libido (sex drive) and have not examined the issue of erectile dysfunction per se." Given that there is a lack of information on the prevalence of ED and the response to its treatment in patients receiving androgen deprivation (hormone) therapy, Derweesh and colleagues at the University of Tennessee Health Science Center studied 395 men treated with ADT at their institution over a period of about 15 years. The average age of the men was 71.7 years and the men were followed for more than 7 years. During that time, 14.4 percent of men reported ED, they report, and 70 percent of these men had "new-onset" ED. According to Derweesh and colleagues, 47 percent of men with erectile dysfunction responded successfully to ED treatment, most often with drugs such as Viagra. "We demonstrate for the first time in a large series," Derweesh noted, that these types of drugs are effective in the treatment of erectile dysfunction caused by androgen deprivation (hormone) therapy. # # # SOURCE: BJU International 2008. NOTE: Issues on this site regarding men's health and their concerns, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment. |
|